beyondthedish.wordpress.com
Capricor Therapeutics Enrolls Patients in HOPE Clinical Trial
The Beverly Hills-based biotechnology company Capricor Therapeutics, Inc. (CAPR) has announced the enrollment of 25 patients for their randomized Phase 1/2 HOPE-Duchenne clinical trial. “HOPE…